UBS cuts target for Icade stock from EUR 17.50 to EUR 13.00

Published on 10/15/2026 at 12:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue fell 4.70 percent to EUR 600.80 million in 2026. Icade stock costs EUR 14.65 on October 15, 2026 versus a EUR 22.76 high.

Target cut and earnings ahead

UBS reduced its Icade target to EUR 13.00 from EUR 17.50 on October 9, 2026.
First-half 2026 revenue fell 4.70 percent to EUR 600.80 million, while annual cash-flow guidance stayed at EUR 2.90-3.10 per share.
Icade stock trades at EUR 14.65 at 12:35 p.m. CEST at Lang & Schwarz on October 15, 2026.

Icade FR0000035081 bildet Makroaufnahme einer strukturierten Glasfassade mit Aluminiumrahmen einer Büroimmobilie ab, Illustration mit AI erstellt.

Icade stock (ISIN FR0000035081) was trading at EUR 14.65 at Lang & Schwarz on October 15, 2026 at 12:35 p.m. CEST. UBS cut its price target for Icade to EUR 13.00 from EUR 17.50 on October 9, 2026, according to Ideal Investor.

Revenue fell in the first half

Icade reported first-half 2026 revenue of EUR 600.80 million, down 4.70 percent from the comparable period. The company also reported a EUR 155.90 million net loss and an adjusted EBITDA margin of 17.40 percent for that period, figures carried by Ideal Investor.

What does the target cut mean?

At EUR 14.65, the new UBS target of EUR 13.00 is 11.26 percent below the Lang & Schwarz price. The target change also leaves the stock 35.71 percent below the former EUR 17.50 objective, while the company's 2026 current net cash-flow guidance remains EUR 2.90-3.10 per share.

Three dated Icade events

On July 22, 2026, Icade published its first-half results and retained its EUR 2.90-3.10 per-share cash-flow guidance, according to Ideal Investor. On September 17, 2026, an Icade and Vilogia project covered 177 homes and 3,000 square meters of offices, as reported by Ideal Investor. On October 9, 2026, UBS cut its target from EUR 17.50 to EUR 13.00.

Next date is October 20

Icade's next reported event is its third-quarter results on October 20, 2026, according to Ideal Investor. That update will give investors a fresh operating checkpoint after the first-half revenue decline and the confirmed cash-flow range.

Valuation remains under pressure

Icade's market capitalization was EUR 1.1 billion on October 15, 2026. Its 52-week range was EUR 14.26 to EUR 22.76, putting the Lang & Schwarz price EUR 8.11 below the high, a 35.61 percent gap based on the quoted euro values.

Stock trades above its yearly low

Icade was trading at EUR 14.65 at Lang & Schwarz on October 15, 2026 at 12:35 p.m. CEST, while its 52-week range stood at EUR 14.26 to EUR 22.76. The further course of trading is shown by the continuously updated real-time quote of Icade stock.